Skip to main content
Veterinary Medicines

G.4

Authorised
  • Gentamicin

Product identification

Medicine name:
G.4
Active substance:
  • Gentamicin
Target species:
  • Cattle (calf)
  • Cat
  • Dog
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Gentamicin
    40000.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle (calf)
      • Meat and offal
        214
        day
    • Cat
    • Dog
  • Intravenous use
    • Cattle (calf)
      • Meat and offal
        214
        day
    • Cat
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01GB03
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • National Veterinary Medicines Agency
Authorisation number:
  • FR/V/0302689 6/1986
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 24/01/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 6/02/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 6/02/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."